Skip to content
Home/GPs/Montagu Private Equity
Montagu Private Equity

Montagu Private Equity

London, United Kingdom·Founded 1968··montagu.com

Montagu Private Equity is a London-based pan-European mid-market buyout firm founded in 1968, focused on management buyouts of resilient businesses with enterprise values typically between EUR 200 million and EUR 1 billion across healthcare, digital infrastructure, financial services, critical data and education. It is authorised by the FCA as an AIFM under Firm Reference Number 460940 and manages around EUR 14 billion of assets.

AUM
€14.0B
Funds
5
vintages 2005–2025
Portfolio
24
Exits
12
SectorsHealthcareTMTBusiness ServicesFinancialsIndustrials

Key facts

HQLondon, United Kingdom
Founded1968
Employees150+

Recent exits

Wireless Logic
TMT · 2025 · 7yr hold
Maincare
HealthTech · 2023 · 5yr hold
DAVASO
Healthcare · 2021 · 4yr hold
Sebia
Healthcare · 2018 · 4yr hold

Coverage notes

5 funds tracked, 36 portfolio companies (24 active · 12 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Montagu Private Equity has raised, with its portfolio companies. Hand-checked from public filings.

5 funds
Wireless Logic Continuation VehicleSecondaries
2025 · 1yr€2.0B1 active

Unrealized

1 held
TMTUK· Entry 2025
Montagu VIBuyout
2020 · 6yr€3.3B15 active · 2 realized

Unrealized

15 held
BMC HelixActive
SoftwareUnited States· Entry 2026
DQSActive
Business ServicesGermany· Entry 2026
TMTFrance· Entry 2021
EXALTAActive
HealthcareUnited States· Entry 2025
Business ServicesFrance· Entry 2020
HarvestActive
FinancialsFrance· Entry 2024
HealthcareFrance· Entry 2021
IAI GroupActive
TMTPoland· Entry 2025
MedTechFrance· Entry 2021
TMTUK· Entry 2020
TMTUK· Entry 2021
TMTUK· Entry 2022
FinancialsLuxembourg· Entry 2025
HealthcareUnited States· Entry 2026
FinancialsIreland· Entry 2021

Realized

2 exits
DAVASOExited 2021
HealthcareGermany· Entry 2017
Trade Saleto
Wireless LogicExited 2025
TMTUK· Entry 2018
GP-ledto
Montagu VBuyout
2015 · 11yr€2.8B8 active · 1 realized

Unrealized

8 held
EvergenActive
HealthcareUnited States· Entry 2020
ConsumerUK· Entry 2016
JanesActive
TMTUK· Entry 2019
MiraclonActive
IndustrialsNetherlands· Entry 2019
NemeraActive
HealthcareFrance· Entry 2019
Business ServicesUK· Entry 2017
ServelecActive
HealthcareUK· Entry 2018
FinancialsGermany· Entry 2017

Realized

1 exit
MaincareExited 2023
HealthTechFrance· Entry 2018
Trade Saleto
Montagu IVBuyout
2011 · 15yr€2.5B0 active · 6 realized

Realized

6 exits
IndustrialsFrance· Entry 2009
Secondaryto
CliniSysExited 2016
HealthcareUK· Entry 2013
Trade Saleto
EmitelExited 2013
IndustrialsPoland· Entry 2011
Trade Saleto
Host EuropeExited 2013
TMTUK· Entry 2010
Secondaryto
SebiaExited 2018
HealthcareFrance· Entry 2014
Secondaryto
Business ServicesUK· Entry 2012
Trade Saleto
Montagu IIIBuyout
2005 · 21yr€2.3B0 active · 3 realized

Realized

3 exits
BSN MedicalExited 2012
HealthcareGermany· Entry 2006
Secondaryto
StabilusExited 2008
IndustrialsGermany· Entry 2004
Secondaryto
SurvitecExited 2010
IndustrialsUK· Entry 2004
Secondaryto
Track Montagu Private Equity

Saved GPs appear in your watchlist, one click from your workspace.

About Montagu Private Equity

Montagu Private Equity is an alternative investment platform with capital deployed across 5 active fund vehicles, headquartered in London. The firm deploys capital across European mid and small-cap businesses spanning TMT, healthcare, industrials, consumer, financials and business services.

Investment thesis

The platform combines complementary investment strategies, deploying capital across TMT, healthcare, industrials, consumer, financials and business services businesses in the United Kingdom and broader European market. Multi-strategy capital deployment enables flexibility across the business lifecycle, with the partnership culture supporting management teams through growth, transmission and selective M&A across multiple fund vintages and asset classes.

Recent activity

Recent realised exits include ADB Airfield Solutions (industrials, 2023). The platform tracks 5 fund vehicles, 33 active portfolio companies and 26 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.

Last updated May 2026 · Sourced from public filings